Low Hb levels at admission associated with higher CV and all cause mortality
New investigation revealed that lower levels of hemoglobin at admission are associated with higher cardiovascular, all-cause mortality, and major ischemic events among elderly patients with the acute coronary syndrome who are managed invasively. The study was published in the "International Journal of Cardiology", 2022.
Hemoglobin (Hb) levels have popped up as a useful tool for risk stratification and the prediction of outcomes after myocardial infarction in patients with cardiovascular issues admitted to a hospital. To understand this, researchers conducted a trial to evaluate the prognostic impact of hemoglobin on elderly patients, where the larger prevalence of anemia and the higher rate of comorbidities could directly impact cardiovascular risk.
Subjects from the ELDERLY-2 trial were included in this analysis. They were stratified according to the values of hemoglobin at admission. Cardiovascular mortality within one year was the primary endpoint of measurement. All-cause mortality, MI, Bleeding Academic Research Consortium (BARC) type 2–3 or 5 bleeding, any stroke, re-hospitalization for a cardiovascular event or stent thrombosis (probable or definite) within 12 months after index admission were the secondary endpoints of measurement.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.